These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2453408)
1. Is first salvage chemotherapy the last-line chemotherapy in children with Hodgkin's disease? A tentative answer based on long observation of two patients. Balwierz W; Armata J; Moryl-Bujakowska A; Pekacki A Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(6):789-96. PubMed ID: 2453408 [TBL] [Abstract][Full Text] [Related]
2. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center]. Arranz R; Gil-Fernández JJ; Muñoz E; Acevedo A; Sobrino MP; Fernández-Rañada JM Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222 [TBL] [Abstract][Full Text] [Related]
3. Pediatric Hodgkin's disease. Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795 [TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure. Campbell B; Wirth A; Milner A; Di Iulio J; MacManus M; Ryan G Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1538-45. PubMed ID: 16125872 [TBL] [Abstract][Full Text] [Related]
5. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy. Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060 [TBL] [Abstract][Full Text] [Related]
6. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors. Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of recurrences of Hodgkin's disease in children]. Armata J; Moryl-Bujakowska A Pol Tyg Lek; 1983 Oct 17-24; 38(42-43):1301-4. PubMed ID: 6201835 [No Abstract] [Full Text] [Related]
9. [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer]. Avigdor A; Hardan I; Shpilberg O; Raanani P; Grotto I; Ben-Bassat I Harefuah; 2000 Sep; 139(5-6):174-9, 248, 247. PubMed ID: 11062945 [TBL] [Abstract][Full Text] [Related]
10. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study. Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131 [TBL] [Abstract][Full Text] [Related]
11. An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV Hybrid program. Klimo P; Connors JM Semin Hematol; 1988 Apr; 25(2 Suppl 2):34-40. PubMed ID: 2456621 [TBL] [Abstract][Full Text] [Related]
12. [Function of the lungs in patients with Hodgkin's disease after chemotherapy and radiotherapy]. Milanowski A; Kulus M; Matysiak M; Ochocka M Pediatr Pol; 1988 Nov; 63(11):747-52. PubMed ID: 2473435 [No Abstract] [Full Text] [Related]
13. [Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications]. Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Stanuch H; Matysiak M; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Raś M; Sońta-Jakimczyk D; Moszant A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Drozyńska E; Wysocki M; Kołtan A; Krawczuk-Rybak M; Stolarska M Przegl Lek; 2004; 61 Suppl 2():33-9. PubMed ID: 15688474 [TBL] [Abstract][Full Text] [Related]
14. Clinical investigations of children with Hodgkin's disease at Stanford University Medical Center. A preliminary overview using low-dose irradiation and alternating ABVD/MOPP chemotherapy. Donaldson SS; Link MP; McDougall IR; Parker BR; Shochat SJ Cancer Treat Res; 1989; 41():307-15. PubMed ID: 2484294 [No Abstract] [Full Text] [Related]
15. [Controversy regarding the treatment of Hodgkin's disease]. Balwierz W; Armata J Pol Tyg Lek; 1989 Apr; 44(14):315-9. PubMed ID: 2482966 [No Abstract] [Full Text] [Related]
16. Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group. Schellong G; Dörffel W; Claviez A; Körholz D; Mann G; Scheel-Walter HG; Bökkerink JP; Riepenhausen M; Lüders H; Pötter R; Rühl U; J Clin Oncol; 2005 Sep; 23(25):6181-9. PubMed ID: 16135485 [TBL] [Abstract][Full Text] [Related]
17. [The management of Hodgkin's disease with chemotherapy or combined modality treatment]. Tsushita K; Utsumi M; Shimoyama M Gan To Kagaku Ryoho; 1998 Dec; 25(14):2202-9. PubMed ID: 9881076 [TBL] [Abstract][Full Text] [Related]
18. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study. Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of Hodgkin's disease in children. Results of the Polish Group for the Treatment of Leukemia and Neoplastic Diseases in Children]. Depowska T; Armata J; Borkowski W Pediatr Pol; 1986 May; 61(5):265-9. PubMed ID: 2431379 [No Abstract] [Full Text] [Related]
20. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results. Comella P; Abate G; Fiore M; Di Finizio G; Frezza P; Scoppa G; Anania C; Coucourde F; Zarrilli D J Chemother; 1989 Jul; 1(4 Suppl):1254-6. PubMed ID: 16312855 [No Abstract] [Full Text] [Related] [Next] [New Search]